194 related articles for article (PubMed ID: 33840010)
1. Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report.
Nagasaki E; Kudo R; Tamura M; Hayashi K; Uwagawa T; Kijima Y; Nogi H; Takeyama H; Suzuki M; Nishikawa M; Yano S; Kobayashi T
Breast Cancer; 2021 Sep; 28(5):1051-1061. PubMed ID: 33840010
[TBL] [Abstract][Full Text] [Related]
2. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review.
Kobayashi T; Ichiba T; Sakuyama T; Arakawa Y; Nagasaki E; Aiba K; Nogi H; Kawase K; Takeyama H; Toriumi Y; Uchida K; Kobayashi M; Kanehira C; Suzuki M; Ando N; Natori K; Kuraishi Y
Breast Cancer; 2012 Jul; 19(3):218-37. PubMed ID: 22532161
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer.
Steenbruggen TG; Schaapveld M; Horlings HM; Sanders J; Hogewoning SJ; Lips EH; Vrancken Peeters MT; Kok NF; Wiersma T; Esserman L; van 't Veer LJ; Linn SC; Siesling S; Sonke GS
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 33977227
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance and low tumor-initiating properties of oligometastatic breast cancer in pulmonary metastasectomy.
Mimoto R; Kobayashi T; Imawari Y; Kamio M; Kato K; Nogi H; Toriumi Y; Hirooka S; Uchida K; Takeyama H
Breast Cancer Res Treat; 2014 Sep; 147(2):317-24. PubMed ID: 25156580
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in patients with oligometastatic breast cancer - A systematic review.
van Ommen-Nijhof A; Steenbruggen TG; Schats W; Wiersma T; Horlings HM; Mann R; Koppert L; van Werkhoven E; Sonke GS; Jager A
Cancer Treat Rev; 2020 Dec; 91():102114. PubMed ID: 33161237
[TBL] [Abstract][Full Text] [Related]
6. Survival and prognostic factors in oligometastatic breast cancer.
van Ommen-Nijhof A; Steenbruggen TG; Capel L; Vergouwen M; Vrancken Peeters MT; Wiersma TG; Sonke GS
Breast; 2023 Feb; 67():14-20. PubMed ID: 36549169
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series.
Lee MY; Chang WJ; Kim HS; Lee JY; Lim SH; Lee JE; Kim SW; Nam SJ; Ahn JS; Im YH; Park YH
PLoS One; 2016; 11(9):e0163254. PubMed ID: 27648567
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment.
Shenouda MN; Sadek BT; Goldberg SI; Keruakous AR; Croft BJ; Abi Raad RF; Taghian AG
Clin Breast Cancer; 2014 Jun; 14(3):198-204. PubMed ID: 24485702
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution.
Lacaze JL; Chira C; Glemarec G; Monselet N; Cassou-Mounat T; De Maio E; Jouve E; Massabeau C; Brac de la Perrière C; Selmes G; Ung M; Nicolai V; Cabarrou B; Dalenc F
Breast Cancer Res Treat; 2023 Apr; 198(3):463-474. PubMed ID: 36790573
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification system for groups with a low, intermediate, and high risk of subsequent distant metastasis and death following isolated locoregional recurrence of breast cancer.
Lee YJ; Park H; Kang CM; Gwark SC; Lee SB; Kim J; Chung IY; Ko BS; Kim HJ; Kim SB; Ahn SD; Gong G; Son BH; Ahn SH; Lee JW
Breast Cancer Res Treat; 2020 Jan; 179(2):315-324. PubMed ID: 31642987
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort.
Steenbruggen TG; Wolf DM; Thijssen B; Sanders J; Cornelissen S; Salgado R; Mittempergher L; Bhaskaran R; Broeks A; Lips EH; Siesling S; Sonke GS; Horlings HM; van 't Veer LJ
JCO Precis Oncol; 2023 Sep; 7():e2200670. PubMed ID: 37738542
[TBL] [Abstract][Full Text] [Related]
12. Prognosis and Treatment of Metastatic Breast Cancer From A Real-World Scenario in China: A Retrospective Cohort Study.
Xie Y; Ma J; Xia X; Zheng H; Gou Q
Cancer Control; 2022; 29():10732748221130568. PubMed ID: 36164749
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.
Christopherson K; Lei X; Barcenas C; Buchholz TA; Garg N; Hoffman KE; Kuerer HM; Mittendorf E; Perkins G; Shaitelman SF; Smith GL; Stauder M; Strom EA; Tereffe W; Woodward WA; Smith BD
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):574-581. PubMed ID: 30851348
[TBL] [Abstract][Full Text] [Related]
14. Oligometastatic Breast Cancer: How to Manage It?
Barberi V; Pietragalla A; Franceschini G; Marazzi F; Paris I; Cognetti F; Masetti R; Scambia G; Fabi A
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34207648
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation.
Waeber M; Castiglione-Gertsch M; Dietrich D; Thürlimann B; Goldhirsch A; Brunner KW; Borner MM;
Ann Oncol; 2003 Aug; 14(8):1215-21. PubMed ID: 12881382
[TBL] [Abstract][Full Text] [Related]
16. A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer.
Murata T; Yoshida M; Shiino S; Ogawa A; Watase C; Satomi K; Jimbo K; Maeshima A; Iwamoto E; Takayama S; Suto A
Breast Cancer Res Treat; 2023 May; 199(1):57-66. PubMed ID: 36869991
[TBL] [Abstract][Full Text] [Related]
17. Role of isolated locoregional recurrence of breast cancer: results of four prospective studies.
Schmoor C; Sauerbrei W; Bastert G; Schumacher M
J Clin Oncol; 2000 Apr; 18(8):1696-708. PubMed ID: 10764430
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer.
Hamilton BK; Rybicki L; Abounader D; Andresen S; Kalaycio M; Sobecks R; Pohlman B; Hanna R; Dean R; Liu H; Hill B; Bolwell B; Copelan E
Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):115-24. PubMed ID: 26183670
[TBL] [Abstract][Full Text] [Related]
20. Therapy of isolated locoregional recurrent carcinoma of the breast.
Gabriel L; Schmidt M; Juhasz-Böss S; Melchior P; von Heesen A; Schmidt G; Kranzhöfer N; Solomayer EF; Juhasz-Böss I; Breitbach GP
Arch Gynecol Obstet; 2019 Aug; 300(2):365-376. PubMed ID: 31222400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
